Literature DB >> 9849357

Functional food science and gastrointestinal physiology and function.

S Salminen1, C Bouley, M C Boutron-Ruault, J H Cummings, A Franck, G R Gibson, E Isolauri, M C Moreau, M Roberfroid, I Rowland.   

Abstract

The gut is an obvious target for the development of functional foods, acting as it does as the interface between diet and the metabolic events which sustain life. The key processes in digestive physiology which can be regulated by modifying diet are satiety, the rate and extent of macronutrient breakdown and absorption from the small bowel, sterol metabolism, the colonic microflora, fermentation, mucosal function and bowel habit, and the gut immune system. The intestinal microflora is the main focus of many current functional foods. Probiotics are foods which contain live bacteria which are beneficial to health whilst prebiotics, such as certain non-digestible oligosaccharides which selectively stimulate the growth of bifidobacteria in the colon, are already on the market. Their claimed benefits are to alleviate lactose maldigestion, increase resistance to invasion by pathogenic species of bacteria in the gut, stimulate the immune system and possibly protect against cancer. There are very few reports of well-designed human intervention studies with prebiotics as yet. Certain probiotic species have been shown to shorten the duration of rotavirus diarrhoea in children but much more work is needed on the mechanism of immunomodulation and of competitive exclusion and microflora modification. The development of functional foods for the gut is in its infancy and will be successful only if more fundamental research is done on digestive physiology, the gut microflora, immune system and mucosal function.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9849357     DOI: 10.1079/bjn19980108

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  162 in total

Review 1.  The influence of yogurt/Lactobacillus on the innate and acquired immune response.

Authors:  Andrea T Borchers; Carl L Keen; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2002-06       Impact factor: 8.667

Review 2.  Intestinal microflora as a therapeutic target in inflammatory bowel disease.

Authors:  Keiichi Mitsuyama; Atsushi Toyonaga; Michio Sata
Journal:  J Gastroenterol       Date:  2002-11       Impact factor: 7.527

3.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

4.  The metabolic activity of fecal microbiota from healthy individuals and patients with inflammatory bowel disease.

Authors:  Marleen H M C van Nuenen; Koen Venema; Janneke C J van der Woude; Ernst J Kuipers
Journal:  Dig Dis Sci       Date:  2004-03       Impact factor: 3.199

5.  Effect of amoxicillin-clavulanic acid on human fecal flora in a gnotobiotic mouse model assessed with fluorescence hybridization using group-specific 16S rRNA probes in combination with flow cytometry.

Authors:  Marie Claude Barc; François Bourlioux; Lionel Rigottier-Gois; Céline Charrin-Sarnel; Claire Janoir; Hélène Boureau; Joël Doré; Anne Collignon
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

6.  Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain.

Authors:  Hojjat Sadeghi-Aliabadi; Fatemeh Mohammadi; Hossain Fazeli; Maryam Mirlohi
Journal:  Iran J Basic Med Sci       Date:  2014-10       Impact factor: 2.699

7.  Bifidobacterial diversity determined by culturing and by 16S rDNA sequence analysis in feces and mucosa from ten healthy Spanish adults.

Authors:  Susana Delgado; Adolfo Suárez; Baltasar Mayo
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

Review 8.  Do probiotics have a therapeutic role in gastroenterology?

Authors:  Jimmy K Limdi; Catherine O'Neill; John McLaughlin
Journal:  World J Gastroenterol       Date:  2006-09-14       Impact factor: 5.742

9.  In vitro fermentation of copra meal hydrolysate by human fecal microbiota.

Authors:  Phatcharin Prayoonthien; Robert A Rastall; Sofia Kolida; Sunee Nitisinprasert; Suttipun Keawsompong
Journal:  3 Biotech       Date:  2019-02-19       Impact factor: 2.406

10.  Folate production by bifidobacteria as a potential probiotic property.

Authors:  Anna Pompei; Lisa Cordisco; Alberto Amaretti; Simona Zanoni; Diego Matteuzzi; Maddalena Rossi
Journal:  Appl Environ Microbiol       Date:  2006-10-27       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.